• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向细胞核的 DNA 四面体作为金属配合物的纳米载体用于增强脑胶质瘤治疗。

Nucleus-targeted DNA tetrahedron as a nanocarrier of metal complexes for enhanced glioma therapy.

机构信息

Department of Chemistry, Jinan University, Guangzhou 510632, China.

出版信息

Chem Commun (Camb). 2018 Aug 21;54(68):9394-9397. doi: 10.1039/c8cc04021d.

DOI:10.1039/c8cc04021d
PMID:29998263
Abstract

A negatively-charged and nucleus-targeted DNA tetrahedron is rationally designed and used as a nanocarrier of positively-charged metal complexes. This tetrahedron speeds up the translocation of metal complexes into the cell nucleus, and inhibits the growth and invasion of glioma cells by triggering vascular mimicry-associated signaling pathways, thus achieving precise glioma treatment.

摘要

一种带负电荷并靶向细胞核的 DNA 四面体被合理设计并用作带正电荷的金属配合物的纳米载体。这种四面体通过触发与血管模拟相关的信号通路,加速金属配合物进入细胞核的转运,并抑制神经胶质瘤细胞的生长和侵袭,从而实现精确的神经胶质瘤治疗。

相似文献

1
Nucleus-targeted DNA tetrahedron as a nanocarrier of metal complexes for enhanced glioma therapy.靶向细胞核的 DNA 四面体作为金属配合物的纳米载体用于增强脑胶质瘤治疗。
Chem Commun (Camb). 2018 Aug 21;54(68):9394-9397. doi: 10.1039/c8cc04021d.
2
A dual-targeting DNA tetrahedron nanocarrier for breast cancer cell imaging and drug delivery.一种用于乳腺癌细胞成像和药物递送的双靶向 DNA 四面体纳米载体。
Talanta. 2018 Mar 1;179:356-363. doi: 10.1016/j.talanta.2017.11.034. Epub 2017 Nov 20.
3
Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics.高电荷、细胞毒性、环金属化铱(III)配合物作为癌症干细胞的线粒体靶向剂。
Chemistry. 2018 Oct 12;24(57):15205-15210. doi: 10.1002/chem.201803521. Epub 2018 Sep 10.
4
Significant effects of counteranions on the anticancer activity of iridium(iii) complexes.抗衡阴离子对铱(III)配合物抗癌活性的显著影响。
Chem Commun (Camb). 2018 Apr 26;54(35):4421-4424. doi: 10.1039/c8cc01326h.
5
Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.新型C,N-环金属化苯并咪唑钌(II)和铱(III)配合物作为抗肿瘤和抗血管生成剂:构效关系研究
J Med Chem. 2015 Sep 24;58(18):7310-27. doi: 10.1021/acs.jmedchem.5b01194. Epub 2015 Sep 4.
6
Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands.含有κP和κP,κS配位的Ph2PCH2CH2CH2S(O)xPh(x = 0 - 2)配体的(五甲基环戊二烯基)氯铱(III)配合物的抗癌潜力
ChemMedChem. 2014 Jul;9(7):1586-93. doi: 10.1002/cmdc.201300479. Epub 2014 Jan 27.
7
Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.基于靶向线粒体和微管的铱(III)配合物的光诱导抗癌活性研究。
Eur J Med Chem. 2018 May 10;151:568-584. doi: 10.1016/j.ejmech.2018.04.013. Epub 2018 Apr 7.
8
Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.香豆素修饰的磷光环金属化铱(III)配合物作为线粒体靶向的诊疗一体化抗癌剂。
Dalton Trans. 2016 Aug 16;45(33):13042-51. doi: 10.1039/c6dt00601a.
9
Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.混合配体钌多吡啶配合物作为癌细胞凋亡诱导剂、细胞转运以及活性氧介导信号传导的重要作用。
Dalton Trans. 2014 Dec 7;43(45):17017-28. doi: 10.1039/c4dt01392a.
10
The induction of apoptosis in SGC-7901 cells through the ROS-mediated mitochondrial dysfunction pathway by a Ir(III) complex.一种铱(III)配合物通过活性氧介导的线粒体功能障碍途径诱导SGC-7901细胞凋亡。
J Biol Inorg Chem. 2016 Dec;21(8):1047-1060. doi: 10.1007/s00775-016-1401-8. Epub 2016 Oct 28.

引用本文的文献

1
Nanocarriers for cutting-edge cancer immunotherapies.用于前沿癌症免疫疗法的纳米载体。
J Transl Med. 2025 Apr 16;23(1):447. doi: 10.1186/s12967-025-06435-0.
2
Current Understanding and Translational Prospects of Tetrahedral Framework Nucleic Acids.四面体骨架核酸的当前理解与转化前景
JACS Au. 2025 Feb 10;5(2):486-520. doi: 10.1021/jacsau.4c01170. eCollection 2025 Feb 24.
3
Nucleolin-Targeting AS1411 Aptamer-Conjugated Nanospheres for Targeted Treatment of Glioblastoma.用于胶质母细胞瘤靶向治疗的核仁素靶向AS1411适配体缀合纳米球
Pharmaceutics. 2024 Apr 21;16(4):566. doi: 10.3390/pharmaceutics16040566.
4
DNA tetrahedral nanostructures for the biomedical application and spatial orientation of biomolecules.用于生物医学应用和生物分子空间定向的DNA四面体纳米结构。
Bioact Mater. 2023 Nov 24;33:279-310. doi: 10.1016/j.bioactmat.2023.10.025. eCollection 2024 Mar.
5
Nanomedicine in cancer therapy.癌症治疗中的纳米医学。
Signal Transduct Target Ther. 2023 Aug 7;8(1):293. doi: 10.1038/s41392-023-01536-y.
6
DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors.基于DNA的纳米材料作为药物递送平台以增强药物在肿瘤中的疗效。
Cancers (Basel). 2023 Apr 5;15(7):2151. doi: 10.3390/cancers15072151.
7
Advances in regenerative medicine applications of tetrahedral framework nucleic acid-based nanomaterials: an expert consensus recommendation.四面体框架核酸纳米材料在再生医学应用中的进展:专家共识推荐。
Int J Oral Sci. 2022 Oct 31;14(1):51. doi: 10.1038/s41368-022-00199-9.
8
Synthesis, Characterization and Antitumor Mechanism Investigation of Heterometallic Ru(Ⅱ)-Re(Ⅰ) Complexes.异金属钌(Ⅱ)-铼(Ⅰ)配合物的合成、表征及抗肿瘤机制研究
Front Chem. 2022 May 27;10:890925. doi: 10.3389/fchem.2022.890925. eCollection 2022.
9
Therapeutic Applications of Programmable DNA Nanostructures.可编程DNA纳米结构的治疗应用
Micromachines (Basel). 2022 Feb 17;13(2):315. doi: 10.3390/mi13020315.
10
Tetrahedral DNA nanostructures for effective treatment of cancer: advances and prospects.四面体 DNA 纳米结构在癌症治疗中的有效性:进展与展望。
J Nanobiotechnology. 2021 Dec 7;19(1):412. doi: 10.1186/s12951-021-01164-0.